Implications of High Rates of Metastatic Prostate Cancer in BRCA2 Mutation Carriers.

Implications of High Rates of Metastatic Prostate Cancer in BRCA2 Mutation Carriers. Prostate. 2016 09; 76(13):1135-45.

View in: PubMed